Word

PSOREAL

Status

Dead

Status Code

709

Status Date

Friday, May 3, 2024

Serial Number

79198733

Registration Number

5308840

Registration Date

Tuesday, October 17, 2017

Mark Type

4

Filing Date

Tuesday, June 7, 2016

Published for Opposition

Tuesday, August 1, 2017

Cancellation Date

Friday, May 3, 2024

Trademark Owner History

LEO Pharma A-S - Original Registrant

Classifications

41 Educational services, namely, conducting classes, seminars and workshops in the field of cancer and dermatological, hematological, renal and endocrine disorders; education services, namely, providing on-line classes, seminars, and workshops in the field of cancer and dermatological, hematological, renal and endocrine disorders; organizing events for educational purposes in the field of pharmaceutical and medical products; providing on-line non-downloadable electronic publications, namely, books, booklets, brochures, papers, periodical publications, magazines, newspapers and newsletters, leaflets, and instructional and teaching materials in the field of cancer and dermatological, hematological, renal and endocrine disorders; publication of electronic books, booklets, brochures, papers, periodical publications, magazines, newspapers and newsletters, leaflets, and instructional and teaching materials in the field of cancer and dermatological, hematological, renal and endocrine disorders; entertainment services, namely, providing online electronic educational and informational games in the field of cancer and dermatological, hematological, renal and endocrine disorders and the treatment thereof

42 Development of pharmaceutical preparations and medicines; pharmaceutical research services; medical research services in the field of cancer and dermatological, hematological, renal and endocrine disorders; conducting clinical trials for others for pharmaceutical products in the field of cancer and dermatological, hematological, renal and endocrine disorders; providing information in the field of cancer and dermatological, hematological, renal and endocrine disorders about the results of clinical trials for pharmaceutical products; providing temporary use of online software applications containing information on the use of pharmaceutical products and for calculating use of medicine

Trademark Events

Dec 27, 2016

Assigned To Examiner

Dec 22, 2016

Sn Assigned For Sect 66a Appl From Ib

Dec 27, 2016

New Application Office Supplied Data Entered

Dec 31, 2016

Application Filing Receipt Mailed

Jan 17, 2017

Non-Final Action Written

Jan 18, 2017

Non-Final Action (Ib Refusal) Prepared For Review

Jan 19, 2017

Refusal Processed By Mpu

Jan 19, 2017

Non-Final Action Mailed - Refusal Sent To Ib

Feb 3, 2017

Refusal Processed By Ib

Feb 22, 2017

Teas Response To Office Action Received

Feb 22, 2017

Teas/Email Correspondence Entered

Feb 22, 2017

Correspondence Received In Law Office

Mar 13, 2017

Non-Final Action Written

Mar 13, 2017

Non-Final Action Mailed

Mar 30, 2017

Teas Response To Office Action Received

Jun 1, 2017

Final Refusal Written

Mar 30, 2017

Teas/Email Correspondence Entered

Mar 30, 2017

Correspondence Received In Law Office

Apr 25, 2017

Non-Final Action Written

Apr 26, 2017

Non-Final Action Mailed

May 8, 2017

Teas Response To Office Action Received

May 8, 2017

Correspondence Received In Law Office

May 8, 2017

Teas/Email Correspondence Entered

Jun 2, 2017

Final Refusal Mailed

Jun 12, 2017

Teas Request For Reconsideration Received

Jun 16, 2017

Approved For Pub - Principal Register

Jul 12, 2017

Notice Of Publication

Aug 1, 2017

Published For Opposition

Sep 1, 2017

Attorney/Dom.Rep.Revoked And/Or Appointed

Oct 17, 2017

Registered-Principal Register

Jan 17, 2018

Final Disposition Notice Created, To Be Sent To Ib

Jan 26, 2018

Final Disposition Processed

Jun 12, 2017

Correspondence Received In Law Office

Jun 12, 2017

Teas/Email Correspondence Entered

Jul 14, 2017

Refusal Processed By Ib

Sep 1, 2017

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

May 21, 2022

New Representative At Ib Received

Oct 17, 2022

Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed

May 3, 2024

Cancelled Section 71

Mar 16, 2018

Final Decision Transaction Processed By Ib

Jan 26, 2018

Final Disposition Notice Sent To Ib